What is LivaNova's accrued litigation?

LivaNova (LIVN) reported accrued litigation of $9.64M in Q1 2026.

How has LivaNova's accrued litigation changed year-over-year?

LivaNova's accrued litigation decreased by 27.0% year-over-year, from $13.21M to $9.64M.

What is the long-term trend for LivaNova's accrued litigation?

Over 5 years (2020 to 2025), LivaNova's accrued litigation has grown at a -15.2% compound annual growth rate (CAGR), from $28.61M to $12.55M.

LivaNova LIVN Accrued litigation

Accrued litigation at other companies

Edwards LifesciencesEW

——

Other financials

Income statement

See full

Revenue$362.3M+14.3%

Gross profit$243.7M+12.7%

Operating income$41.5M-14.7%

Net income$22.3M+107%

EPS (diluted)$0.40+107%

Balance sheet

See full

Cash & equivalents$539.7M-26.9%

Total debt$340.9M-49.7%

Total equity$1.2B+17.1%

Total assets$2.5B-1.7%

Cash flow

See full

Operating cash flow$15.2M-36.5%

CapEx$14.3M+32.4%

Free cash flow$926.0K-93.0%

Valuation

See full

Market cap$4.32B+62.8%

Profitability

See full

Gross margin67.5%-0.5pp

Operating margin13.4%+0.8pp

Net margin-16.1%-18.0pp

FCF margin11.2%-0.2pp

Returns & leverage

See full

Return on equity-17.6%-19.5pp

Debt / equity0.3×-0.4×

Current ratio1.3×-0.2×

Where this comes from

Reported directly by LivaNova in its filing.

Tagged under the XBRL concept us-gaap:LitigationReserveCurrent.

The official record: LivaNova’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about LivaNova's accrued litigation.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is LivaNova's accrued litigation?: LivaNova (LIVN) reported accrued litigation of $9.64M in Q1 2026.
How has LivaNova's accrued litigation changed year-over-year?: LivaNova's accrued litigation decreased by 27.0% year-over-year, from $13.21M to $9.64M.
What is the long-term trend for LivaNova's accrued litigation?: Over 5 years (2020 to 2025), LivaNova's accrued litigation has grown at a -15.2% compound annual growth rate (CAGR), from $28.61M to $12.55M.